| ➡️ Get instant news updates on Whatsapp. Click here to join our Whatsapp Group. |
The Influx Healthtech IPO will open for subscription on June 18, 2025, and will close on June 20, 2025. This IPO is a Book Build Issue, with the company aiming to raise around ₹58.57 crores. The issue includes a fresh issue of ₹48.00 crores and an offer for sale (OFS) of up to 11,00,400 equity shares, each having a face value of ₹10.
The price band for the Influx Healthtech IPO is fixed between ₹91 to ₹96 per share. The IPO allocation is divided as follows:
- Qualified Institutional Buyers (QIBs): 50%
- Retail Investors: 35%
- High Net-Worth Individuals (HNIs): 15%
The basis of allotment will be finalized on June 23, 2025, and the shares are expected to be listed on the NSE on June 25, 2025.
Influx Healthtech IPO Details
- IPO Open Date: June 18, 2025
- IPO Close Date: June 20, 2025
- Face Value: ₹10 per equity share
- Price Band: ₹91 to ₹96 per share
- Total Issue Size: Approximately ₹58.57 crores
- Fresh Issue: Around ₹48.00 crores
- Offer for Sale (OFS): Around 11,00,400 equity shares
- Issue Type: Book Build Issue
- Listing Exchange: NSE SME platform
- Retail Investor Quota: Not more than 35%
- Qualified Institutional Buyers (QIB) Quota: Not more than 50%
- Non-Institutional Investors (NII) Quota: Not more than 15%
- Draft Red Herring Prospectus (DRHP): Click Here
- Red Herring Prospectus (RHP): Click Here
Influx Healthtech IPO: Market Lot and Investment Details
- Minimum Lot Size: 1 lot (1,200 shares)
- Minimum Investment Amount (Retail): ₹1,15,200
- Maximum Investment Amount (Retail): ₹1,15,200
- Minimum Investment Amount (S-HNI): ₹2,30,400 (2 lots or 2,400 shares)
| Application Type | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 1,200 | ₹1,15,200 |
| Retail Maximum | 1 | 1,200 | ₹1,15,200 |
| S-HNI Minimum | 2 | 2,400 | ₹2,30,400 |
Influx Healthtech IPO Dates and Timelines
- IPO Opening Date: June 18, 2025
- IPO Closing Date: June 20, 2025
- Basis of Allotment: June 23, 2025
- Refunds Initiation: June 24, 2025
- Credit of Shares to Demat: June 24, 2025
- IPO Listing Date: June 25, 2025
Influx Healthtech IPO Promoters
- Mr. Munir Abdul Ganee Chandniwala
- Mrs. Shirin Munir Ahmed Chandniwala
- Mr. Abdul Ganee Abdul Rasul Chandniwala
About Influx Healthtech Limited
Influx Healthtech Limited, established in 2020, is a contract development and manufacturing organization (CDMO) in the healthcare sector. The company specializes in manufacturing and developing dietary supplements, cosmetics, ayurvedic products, veterinary feed supplements, and homecare items. Its production units are located in Thane, Maharashtra, covering spaces of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft.
Influx Healthtech serves several major clients, including:
- Bling Brands
- Pursuit of Wellness
- Aarkios Health
- HSHS Nutraceuticals
- Novus Life Science
- Bruder Life Science
- Fredun Pharmaceuticals
- BigFlex Lifescience
The company employs 165 permanent staff and is known for maintaining high safety, quality, and regulatory standards.
Influx Healthtech Financial Performance
Figures in ₹ Crores
| Financial Year | Revenue | Expenses | Net Profit | Assets |
|---|---|---|---|---|
| FY 2023 | 76.06 | 66.32 | 7.20 | 28.30 |
| FY 2024 | 100.02 | 85.08 | 11.13 | 41.10 |
| FY 2025 | 104.99 | 87.11 | 13.37 | 70.30 |
Influx Healthtech Valuation – FY2025
| Key Metric | Value |
|---|---|
| Return on Equity (ROE) | 36.98% |
| Return on Capital Employed (ROCE) | 49.17% |
| EBITDA Margin | 19.62% |
| PAT Margin | 12.75% |
| Debt-to-Equity Ratio | 0.01 |
| Earnings Per Share (EPS) | ₹7.36 (Basic) |
| Price/Earnings Ratio | Not Available |
| Return on Net Worth (RoNW) | 36.98% |
| Net Asset Value (NAV) | ₹19.91 |
Peer Comparison
| Company Name | EPS | P/E Ratio | RoNW | NAV | Revenue |
|---|---|---|---|---|---|
| Sudarshan Pharma Industries Ltd. | 0.66 | 48.28 | 12.45% | 5.30 | ₹505.38 Crores |
| Quest Laboratories Ltd. | 8.28 | 10.38 | 16.58% | 49.92 | ₹108.16 Crores |
Objects of the Issue
- Setting up a nutraceutical manufacturing facility
- Establishing a veterinary food production unit
- Purchase of machinery for homecare and cosmetics
- General corporate purposes
Analyst Reviews for Influx Healthtech IPO
Brokerages and financial firms tracking the IPO include:
- Canara Bank
- DRChoksey FinServ
- Emkay Global
- Hem Securities
- IDBI Capital
- Marwadi Shares
- Nirmal Bang
- SBICAP Securities
- Sharekhan
- SMC Global
- Sushil Finance
- Swastika Investmart
- Ventura Securities
- Geojit
- Reliance Securities
- Capital Market
- BP Wealth
- ICICIdirect
- Choice Broking
IPO Registrar Details
Registrar: Maashitla Securities Private Limited
Phone: +91-11-45121795-96
Email: investor.ipo@maashitla.com
Website: https://maashitla.com
Lead Manager (Merchant Banker)
- Merchant Banker: Rarever Financial Advisors Pvt. Ltd.
Company Contact Information
Address:
Influx Healthtech Limited
109, Ghanshyam Enclave Premises Co-op Soc,
Plot No. 856, Laljipada,
Kandivali West, Mumbai, Maharashtra
Phone: +91 7045997809
Email: cs@influxhealthtech.com
Website: https://influxhealthtech.com
Frequently Asked Questions (FAQs)
Q1. What is Influx Healthtech IPO?
It is an SME IPO to raise ₹58.57 crores with a price band of ₹91 to ₹96 per share. It will be listed on the NSE SME platform.
Q2. When is the IPO open for subscription?
The IPO will be open from June 18 to June 20, 2025 for QIBs, NIIs, and retail investors.
Q3. What are the investor quotas in the IPO?
- QIB: 50%
- NII: 15%
- Retail: 35%
How to Apply for Influx Healthtech IPO?
You can apply for the Influx Healthtech IPO in the following ways:
- Online through ASBA via your bank’s net banking platform.
- Online through UPI via stock brokers offering IPO applications.
- Offline by submitting a physical application form through your stock broker.
-
-
-
-
-
-
-
-
-
-
-
-
